Illumina, Inc. ILMN | NASDAQ

$136.02 $2.02 | 1.51%

After Hours
$137.75 $1.73 | 1.27%

Company Overview:

Market Cap: $21.57B
PE Ratio: -13.64
52-Week Range: $97.363815 - $156.66
Dividend Yield (FWD): 0.00% ($0.00)

10 Year Performance Metrics:

Total Return (with DRIP): -28.20% (-3.26% / yr)
Total Return (no DRIP): -28.20% (-3.26% / yr)
Share Price: -28.20%
Dividend Increase: nan%
ILMN 10-yr Total Return ($10,000 investment)
1Y 2Y 5Y 10Y All

ILMN Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
ILMN Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Share Price
ILMN Price CAGR:1Y: -0.64%2Y: -15.71%5Y: -16.25%10Y: -3.29%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

ILMN Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.

Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.

FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.

Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.

Dividend Payout Ratio - ILMN
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - ILMN
14-Day FREE Trial Get Full Access Now!

ILMN Earnings, Revenue, Cash & Debt, Shares Outstaning:

ILMN - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
ILMN - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
ILMN - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
ILMN - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
ILMN - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
ILMN - Cash & Debt
14-Day FREE Trial Get Full Access Now!
ILMN - Revenue
14-Day FREE Trial Get Full Access Now!
ILMN Revenue CAGR:1Y: -3.49%2Y: -1.58%5Y: 3.55%10Y: 8.43%
ILMN - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
ILMN EPS CAGR:1Y: 192.45%2Y: 47.70%5Y: 22.79%10Y: 21.48%
ILMN - Net Income
14-Day FREE Trial Get Full Access Now!
ILMN Net Income CAGR:1Y: 193.50%2Y: 47.81%5Y: 24.68%10Y: 22.39%
ILMN - EBITDA
14-Day FREE Trial Get Full Access Now!
ILMN EBITDA CAGR:1Y: -6.77%2Y: -55.38%5Y: 21.81%10Y: 19.56%
ILMN - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
ILMN Free Cash Flow CAGR:1Y: 202.13%2Y: 71.84%5Y: 5.43%10Y: 9.88%
ILMN - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
ILMN Free Cash Flow / Share CAGR:1Y: 200.23%2Y: 71.49%5Y: 3.79%10Y: 8.58%
ILMN - Gross Profit
14-Day FREE Trial Get Full Access Now!
ILMN Gross Profit CAGR:1Y: 8.92%2Y: 1.93%5Y: 2.83%10Y: 8.35%
ILMN - Expenses
14-Day FREE Trial Get Full Access Now!
ILMN Expenses CAGR:1Y: -28.89%2Y: -63.93%5Y: -8.17%10Y: -0.87%
ILMN - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
ILMN Shares Outstanding CAGR:1Y: 1.27%2Y: 0.95%5Y: 1.57%10Y: 0.82%
ILMN - Share Buybacks
14-Day FREE Trial Get Full Access Now!
ILMN Share Buybacks CAGR:1Y: 4,850.00%2Y: 603.56%5Y: -12.94%10Y: N/A
ILMN - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
ILMN Stock-Based Comp CAGR:1Y: -4.60%2Y: 0.00%5Y: 12.53%10Y: 6.39%
ILMN - Dividends
14-Day FREE Trial Get Full Access Now!
ILMN Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
ILMN - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
ILMN Revenue CAGR:1Y: -3.49%2Y: -1.58%5Y: 3.55%10Y: 8.43%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

ILMN - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ILMN Actual Revenue CAGR:1Y: -3.49%2Y: -1.58%5Y: 3.55%10Y: 8.43%
ILMN - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ILMN Actual EPS CAGR:1Y: 192.45%2Y: 47.70%5Y: 22.79%10Y: 21.48%
ILMN - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ILMN Actual Net Income CAGR:1Y: 193.50%2Y: 47.81%5Y: 24.68%10Y: 22.39%
ILMN - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ILMN Actual EBITDA CAGR:1Y: -6.77%2Y: -55.38%5Y: 21.81%10Y: 19.56%

Ratios, Profit Margins & Return on Capital:

ILMN - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
ILMN Net Profit Margin CAGR:1Y: 196.88%2Y: 48.01%5Y: 20.40%10Y: 12.87%
ILMN - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
ILMN Gross Profit Margin CAGR:1Y: 12.84%2Y: 3.58%5Y: -0.70%10Y: -0.07%
ILMN - Price to Earnings
14-Day FREE Trial Get Full Access Now!
ILMN - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
ILMN - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
ILMN - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

ILMN Dividends Info:

Annual Dividend: $
Forward Yield: 0%
Ex-Dividend Date:
Lifetime Dividens / Share: $0.00

ILMN Dividend History: Dates, Payments & Yield list

Below is a schedule of all ILMN dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Returns & Dividends for ILMN

Based on past 10-year performance, here are ILMN growth metrics:

Share price CAGR of -3.26%
Dividend CAGR of +0%
Using ILMN CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:

ILMN
Current Price$136.02
Start Shares73.52
Start Value$10,000
 
After 10 years:
Final Share Count73.52
Dividends Payment$0.00
Annual Dividends$0
Yield on cost0.00%
Share Price$100.96
Total Dividends$0
Final Value$7,422

Estimated Future Value + Dividends - ILMN

NOTE: Above numbers are our estimate based on ILMN's Dividend and Price CAGR over past 10 years. These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these estimates.

Company Info

Illumina, Inc. (ILMN) had its IPO on 2000-07-28, and is trader on NASDAQ stock exchange.

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.

ILMN website: https://www.illumina.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial